Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Phosphoinositide kinases

C L Carpenter1, L C Cantley

  • 1Department of Medicine, Beth Israel Hospital, Boston, MA 02215, USA.

Current Opinion in Cell Biology
|April 1, 1996
PubMed
Summary
This summary is machine-generated.

Researchers identified new cDNA clones related to phosphoinositide 3-kinase. Studies using inhibitors and mutants revealed its role in cell motility, signaling pathways, and secretion.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Phase I dose escalation study of the PI3kinase pathway inhibitor BKM120 and the oral poly (ADP ribose) polymerase (PARP) inhibitor olaparib for the treatment of high-grade serous ovarian and breast cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2016
Same author

Metabolic pathway alterations that support cell proliferation.

Cold Spring Harbor symposia on quantitative biology·2012
Same author

The SRC-associated protein CUB Domain-Containing Protein-1 regulates adhesion and motility.

Oncogene·2011
Same author

Prognostic significance of AMP-activated protein kinase expression and modifying effect of MAPK3/1 in colorectal cancer.

British journal of cancer·2010
Same author

PI3K pathway alterations in cancer: variations on a theme.

Oncogene·2008
Same author

Complementary and alternative therapies among very long-term breast cancer survivors.

Breast cancer research and treatment·2008
Same journal

Mechanosensing in immune cells: Implications for migration and beyond.

Current opinion in cell biology·2026
Same journal

Emerging role of organelles in cell migration.

Current opinion in cell biology·2026
Same journal

Nuclear adaptation in cell migration.

Current opinion in cell biology·2026
Same journal

Patterns in motion: Choreographing dynamic cell behaviours during tissue repair.

Current opinion in cell biology·2026
Same journal

Quo vadis reconstituted cell surfaces? Purpose and future perspectives for minimal systems of the cell plasma membrane.

Current opinion in cell biology·2026
Same journal

Nuclear determinants of mRNA and protein isoforms.

Current opinion in cell biology·2026
See all related articles

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Background:

  • Recent identification of cDNA clones homologous to phosphoinositide 3-kinase (PI3K) catalytic subunit.
  • Publication of the first cDNA clone encoding phosphatidylinositol 4-phosphate 5-kinase.

Purpose of the Study:

  • To elucidate the functions of phosphoinositide 3-kinase in cellular processes.
  • To identify key cellular pathways regulated by PI3K.

Main Methods:

  • Utilizing dominant-negative mutants of phosphoinositide 3-kinase.
  • Employing specific inhibitors such as wortmannin and LY294002.
  • Sequence analysis of novel cDNA clones.

Main Results:

  • PI3K is implicated in diverse cellular functions including cell motility.

Related Experiment Videos

  • PI3K plays a role in the Ras signaling pathway.
  • Involvement of PI3K in vesicle trafficking, secretion, and apoptosis confirmed.
  • Identification of potential biochemical targets for phosphoinositides.

    • Conclusions:

    • Phosphoinositide 3-kinase is a critical regulator of multiple cellular processes.
    • Further research into PI3K targets may reveal new therapeutic strategies.
    • The identified cDNA clones provide tools for deeper investigation into PI3K signaling.